Genus Schedules Special Shareholder Meeting to Vote on AIXTRON Merger
February 09 2005 - 3:30AM
PR Newswire (US)
Genus Schedules Special Shareholder Meeting to Vote on AIXTRON
Merger SUNNYVALE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Genus,
Inc. (NASDAQ:GGNS) announced today that it will host a special
meeting of shareholders at 9:00 a.m. local time on Thursday, March
10, 2005, to vote on its previously announced merger with AIXTRON
AG of Aachen, Germany. The meeting will be held at Genus
headquarters, located at 1139 Karlstad Drive, Sunnyvale, Calif.
Genus set Friday, February 4, 2005 as the record date for the
determination of shareholders entitled to vote at the special
meeting. AIXTRON will send a definitive proxy statement/prospectus
to all Genus shareholders of record as of the record date. The
definitive proxy statement/prospectus will contain important
information regarding the previously announced merger. Genus also
confirmed that it will not announce financial results for the
fourth quarter or the year ended December 31, 2004 as a stand-alone
company, and Genus therefore will not host an investor conference
call. About Genus Genus, Inc. manufactures critical deposition
processing products for the global semiconductor industry and the
data storage industry. To enable the production of intricate micro
computer chips and electronic storage devices, Genus offers its
StrataGem and LYNX series production-proven equipment for 200 mm
and 300 mm semiconductor production, and offers thin film
deposition products for chemical vapor deposition (CVD), atomic
layer deposition (ALD), and pre-clean capabilities. Genus is at the
forefront of market and technology developments in the ALD
marketplace, which is gaining acceptance worldwide as a critical
technology for sub 0.13-micron production of computer chips and
electronic storage devices. Genus' customers include semiconductor
and data storage manufacturers located throughout the United
States, Europe and the Pacific Rim including Korea, Japan and
Taiwan. Founded in 1981, the company is headquartered in Sunnyvale,
California. For additional information visit Genus' web site at
http://www.genus.com/. LYNX2(R) and LYNX3(TM) are trademarks of
Genus, Inc. Forward-Looking Statements This document may contain
forward-looking statements about the financial conditions, results
of operations and earnings outlook of AIXTRON and Genus within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Words such as "expects,"
"anticipates," "intends," "plans," "believes," and "estimates," and
variations of these words and similar expressions, identify these
forward-looking statements. These statements are not guarantees of
future performance, involve certain risks, uncertainties and
assumptions that are difficult to predict, and are based upon
assumptions as to future events that may not prove accurate.
Therefore, actual outcomes and results may differ materially from
what is expressed herein. For example, if Genus does not receive
required shareholder approval or either Genus or AIXTRON fail to
satisfy other conditions to closing, the transaction will not be
consummated. In any forward-looking statement in which AIXTRON or
Genus expresses an expectation or belief as to future results, such
expectation or belief is expressed in good faith and believed to
have a reasonable basis, but there can be no assurance that the
statement or expectation or belief will result or be achieved or
accomplished. Actual operating results may differ materially from
such forward-looking statements and are subject to certain risks,
including risks arising from: actual customer orders received by
the companies; the extent to which MOCVD and ALD technology is
demanded by the market place; the actual number of customer orders
received by the companies; the timing of final acceptance of
products by customers; the financial climate and accessibility of
financing, general conditions in the thin film equipment market and
in the macro-economy; cancellations, rescheduling or delays in
product shipments; manufacturing capacity constraints; lengthy
sales and qualification cycles; difficulties in the production
process; changes in semiconductor industry growth; increased
competition; delays in developing and commercializing new products;
general economic conditions being less favorable than expected; the
risk that the AIXTRON and Genus businesses will not be integrated
successfully; costs related to the proposed merger; failure of the
Genus shareholders to approve the proposed merger or the failure of
other conditions to the proposed merger to be satisfied; and other
factors, including those set forth in Genus's filings with the U.S.
Securities and Exchange Commission, including its Annual Report on
Form 10-K for its most recent fiscal year and its most recent
Quarterly Report on Form 10-Q, particularly in the "Risk Factors"
and "Management's Discussion and Analysis of Financial Condition
and Results of Operations" sections, and its Current Reports on
Form 8-K. The forward-looking statements contained in this news
release are made as of the date hereof and AIXTRON and Genus do not
assume any obligation to (and expressly disclaim any such
obligation to) update the reasons why actual results could differ
materially from those projected in the forward-looking statements.
Any reference to the Internet website of AIXTRON or Genus is not an
incorporation by reference of such information in this press
release, and you should not interpret such a reference as an
incorporation by reference of such information. Additional
Information AIXTRON and Genus entered into a definitive merger
agreement on July 1, 2004. AIXTRON has filed a registration
statement on Form F-4 with the U.S. Securities and Exchange
Commission, or SEC, which includes a prospectus of AIXTRON and a
proxy statement of Genus. Investors and security holders are urged
to read the proxy statement/prospectus regarding the business
combination transaction referenced in the foregoing information
because it will contain important information. Investors and
security holders may obtain a free copy of the proxy
statement/prospectus and other documents filed by AIXTRON and Genus
with the SEC at the SEC's website at http://www.sec.gov/. The proxy
statement/prospectus and these other documents may also be obtained
for free from AIXTRON by directing a request to AIXTRON Investor
Relations at Kackertstr.15-17, 52072 Aachen, +49 241 8909 444 or
from Genus, by directing a request to Genus Investor Relations at
1139 Karlstad Drive, Sunnyvale, Calif. 94089, (408) 747-7140 Ext.
1311. Certain Participants AIXTRON and its directors and executive
officers may be deemed to be participants in the solicitation of
proxies from the shareholders of Genus in connection with the
merger. Information regarding the special interests of these
directors and executive officers in the merger will be included in
the proxy statement/prospectus described above. Genus and its
directors and executive officers may be deemed to be participants
in the solicitation of proxies from the shareholders of Genus in
connection with the merger. Information regarding the special
interests of these directors and executive officers in the merger
will be included in the proxy statement/prospectus described above.
DATASOURCE: Genus, Inc. CONTACT: Genus Investor Relations,
+1-408-747-7140, ext. 1311 Web site: http://www.genus.com/
Copyright
Genus (NASDAQ:GGNS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Genus (NASDAQ:GGNS)
Historical Stock Chart
From Oct 2023 to Oct 2024